About: Capacity building in national influenza laboratories – use of laboratory assessments to drive progress

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Capacity building in national influenza laboratories – use of laboratory assessments to drive progress Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Capacity building in national influenza laboratories – use of laboratory assessments to drive progress
Creator	Balish, Amanda Moen, Ann Aden, Tricia Kennedy, Pam Lindstrom, Steven Johnson, Lucinda Muir-Paulik, Sarah
Source	Medline; PMC
abstract	BACKGROUND: Laboratory testing is a fundamental component of influenza surveillance for detecting novel strains with pandemic potential and informing biannual vaccine strain selection. The United States (U.S.) Centers for Disease Control and Prevention (CDC), under the auspices of its WHO Collaborating Center for Influenza, is one of the major public health agencies which provides support globally to build national capacity for influenza surveillance. Our main objective was to determine if laboratory assessments supported capacity building efforts for improved global influenza surveillance. METHODS: In 2010, 35 national influenza laboratories were assessed in 34 countries, using a standardized tool. Post-assessment, each laboratory received a report with a list of recommendations for improvement. Uptake of recommendations were reviewed 3.2 mean years after the initial assessments and categorized as complete, in-progress, no action or no update. This was a retrospective study; follow-up took place through routine project management rather than at a set time-point post-assessment. WHO data on National Influenza Centre (NIC) designation, External Quality Assessment Project (EQAP) participation and FluNet reporting was used to measure laboratory capacity longitudinally and independently of the assessments. All data was further stratified by World Bank country income category. RESULTS: At follow-up, 81 % of 614 recommendations were either complete (350) or in-progress (145) for 32 laboratories (91 % response rate). The number of countries reporting to FluNet and the number of specimens they reported annually increased between 2005, when they were first funded by CDC, and 2010, the assessment year (p < 0.01). Improvements were also seen in EQAP participation and NIC designation over time and more so for low and lower-middle income countries. CONCLUSIONS: Assessments using a standardized tool have been beneficial to improving laboratory-based influenza surveillance. Specific recommendations helped countries identify and prioritize areas for improvement. Data from assessments helped CDC focus its technical assistance by country and region. Low and lower-middle income countries made greater improvements in their laboratories compared with upper-middle income countries. Future research could include an analysis of annual funding and technical assistance by country. Our approach serves as an example for capacity building for other diseases.
has issue date	2015-11-06(xsd:dateTime)
bibo:doi	10.1186/s12879-015-1232-1
bibo:pmid	26546333
has license	cc-by
sha1sum (hex)	543819a7a29de2c78dd6e147beed7be72466c610
schema:url	https://doi.org/10.1186/s12879-015-1232-1
resource representing a document's title	Capacity building in national influenza laboratories – use of laboratory assessments to drive progress
has PubMed Central identifier	PMC4636816
has PubMed identifier	26546333
schema:publication	BMC Infect Dis
resource representing a document's body	covid:543819a7a29de2c78dd6e147beed7be72466c610#body_text
is schema:about of	named entity 'Influenza' named entity 'WHO Collaborating Center' named entity '2010' named entity 'tool' named entity 'agencies' named entity 'annually' named entity 'capacity building' named entity 'annual' named entity 'PROGRESS' named entity 'CAPACITY BUILDING' named entity 'PARTICIPATION' covid:arg/543819a7a29de2c78dd6e147beed7be72466c610 named entity 'RECOMMENDATIONS' named entity 'LABORATORY' named entity 'ASSESSMENTS' named entity 'YEAR' named entity 'DISEASES' named entity 'LABORATORY' named entity 'ANALYSIS' named entity 'ROUTINE' named entity 'UPDATE' named entity 'RATHER' named entity 'THEIR' named entity 'USED' named entity 'COUNTRIES' named entity 'GLOBALLY' named entity 'FOLLOW-UP' named entity 'CATEGORY' named entity 'FOCUS' named entity 'IMPROVEMENT' named entity 'ANNUAL' named entity 'IDENTIFY' named entity 'CONCLUSIONS' named entity 'REGION' named entity 'DATA' named entity 'WORLD BANK' named entity 'CAPACITY' named entity 'HEALTH AGENCIES' named entity 'IMPROVING' named entity 'BUILD' named entity 'SPECIFIC' named entity 'YEARS' named entity 'INFLUENZA' named entity 'OUR' named entity 'GREATER' named entity 'INITIAL' named entity 'LOWER' named entity 'ANNUALLY' named entity 'NATIONAL' named entity 'USE OF' named entity 'TOOL' named entity 'RECEIVED' named entity 'RESEARCH' named entity 'WAS A' named entity 'RESULTS' named entity 'COUNTRY' named entity 'ASSESSMENT' named entity 'UPTAKE' named entity 'CENTERS FOR DISEASE CONTROL AND PREVENTION' named entity 'SET' named entity 'REVIEWED' named entity '28P' named entity 'INFLUENZA' named entity 'REPORTED' named entity 'CENTRE' named entity 'SUPPORT' named entity 'PROVIDES' named entity 'MEAN' named entity 'PROJECT' named entity 'VACCINE STRAIN' named entity 'NIC' named entity 'COMPLETE' named entity 'MAIN' named entity 'LIST' named entity 'INCLUDE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software